IM Insight Molecular Diagnostics Inc. Stock: price and management transactions · United States · SEC (Form 4)Source id SEC:insight-molecular-diagnostics-inc-e6c14d US · SEC (Form 4) Mcap US$754.4k Follow the Insight Molecular Diagnostics Inc. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €754k. The latest transaction was disclosed on 6 July 2026 (Retenue fiscale). Among the most active insiders: BROADWOOD PARTNERS, L.P.. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 6 July 2026
All Executives25 Thresholds0 Prospectus0 Other0
Declarations 25 total
● Director · Executives · 1 Jul 2026
12,100 shares @ US$5.69 100.0% of flow Common Stock, no par value SEC:0001493152-26-032231:0
● Director · Executives · 1 Jul 2026
7,700 shares @ US$5.69 100.0% of flow Common Stock, no par value SEC:0001493152-26-032233:0
● Director · Executives · 1 Jul 2026
7,700 shares @ US$5.69 100.0% of flow Common Stock, no par value SEC:0001493152-26-032235:0
◆ Director · Executives · 11 Jun 2026
32,331 shares Common Stock, no par value SEC:0001493152-26-028753:0
▲ 10% Owner · Executives · 23 Apr 2026
00Common Stock, no par value SEC:0000919574-26-002414:1
Canonical exit: 22 Jul 2026 (T+90) ▲ 10% Owner · Executives · 24 Apr 2026
00Common Stock, no par value SEC:0000919574-26-002414:3
Canonical exit: 23 Jul 2026 (T+90) ▲ 10% Owner · Executives · 27 Apr 2026
00Common Stock, no par value SEC:0000919574-26-002414:5
Canonical exit: 26 Jul 2026 (T+90) ▲ 10% Owner · Executives · 23 Apr 2026
280,381 shares @ US$3.5025 48.4% of flow Common Stock, no par value SEC:0000919574-26-002414:0
Canonical exit: 22 Jul 2026 (T+90) ▲ 10% Owner · Executives · 27 Apr 2026
250,923 shares @ US$3.6391 44.8% of flow Common Stock, no par value SEC:0000919574-26-002414:4
Canonical exit: 26 Jul 2026 (T+90) ▲ 10% Owner · Executives · 24 Apr 2026
38,880 shares @ US$3.5258 6.8% of flow Common Stock, no par value SEC:0000919574-26-002414:2
Canonical exit: 23 Jul 2026 (T+90) ▲ 10% Owner · Executives · 16 Apr 2026
00Common Stock, no par value SEC:0000919574-26-002306:1
Canonical exit: 15 Jul 2026 (T+90) ▲ 10% Owner · Executives · 17 Apr 2026
00Common Stock, no par value SEC:0000919574-26-002306:3
Canonical exit: 16 Jul 2026 (T+90) ▲ 10% Owner · Executives · 20 Apr 2026
00Common Stock, no par value SEC:0000919574-26-002306:5
Canonical exit: 19 Jul 2026 (T+90) ▲ 10% Owner · Executives · 16 Apr 2026
102,057 shares @ US$3.4457 13.0% of flow Common Stock, no par value SEC:0000919574-26-002306:0
Canonical exit: 15 Jul 2026 (T+90) ▲ 10% Owner · Executives · 17 Apr 2026
40,114 shares @ US$3.5711 5.3% of flow Common Stock, no par value SEC:0000919574-26-002306:2
Canonical exit: 16 Jul 2026 (T+90) ▲ 10% Owner · Executives · 20 Apr 2026
40,690 shares @ US$3.8822 5.9% of flow Common Stock, no par value SEC:0000919574-26-002306:4
Canonical exit: 19 Jul 2026 (T+90) ◇ Chief Financial Officer · Executives · 26 Mar 2026
28,302 shares Common Stock SEC:0001493152-26-013574:0
◇ VP ACCT, Cntlr, Treasurer, PAO · Executives · 26 Mar 2026
6,289 shares Common Stock SEC:0001493152-26-013572:0
◇ CEO and President · Executives · 26 Mar 2026
47,170 shares Common Stock SEC:0001493152-26-013571:0
521,739 shares @ US$5.75 52.4% of flow Common Stock, no par value SEC:0000919574-26-000779:0
Canonical exit: 11 May 2026 (T+90) ◇ Chief Financial Officer · Executives · 31 Oct 2025
50,000 shares 0Common Stock SEC:0001493152-25-022358:0
◇ Chief Financial Officer · Executives · 31 Oct 2025
50,000 shares 0Common Stock SEC:0001493152-25-020719:0
◆ Director · Executives · 1 Jul 2025
55,000 shares 0Common Stock, no par value SEC:0001641172-25-017798:0
◆ Director · Executives · 1 Jul 2025
35,000 shares 0Common Stock, no par value SEC:0001641172-25-017796:0
◆ Director · Executives · 1 Jul 2025
35,000 shares 0Common Stock, no par value SEC:0001641172-25-017787:0
关于 Insight Molecular Diagnostics Inc. Insight Molecular Diagnostics Inc. 是一家专注于开发分子诊断测试的公司。它旨在通过创新解决方案改善医疗保健。